Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H34O |
Molecular Weight | 290.4834 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CO
InChI
InChIKey=OJISWRZIEWCUBN-QIRCYJPOSA-N
InChI=1S/C20H34O/c1-17(2)9-6-10-18(3)11-7-12-19(4)13-8-14-20(5)15-16-21/h9,11,13,15,21H,6-8,10,12,14,16H2,1-5H3/b18-11+,19-13+,20-15+
Molecular Formula | C20H34O |
Molecular Weight | 290.4834 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0036035 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14715241 |
PubMed
Title | Date | PubMed |
---|---|---|
Geranylgeraniol potentiates lovastatin inhibition of oncogenic H-Ras processing and signaling while preventing cytotoxicity. | 1997 Jan 23 |
|
Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. | 1997 Oct 30 |
|
Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB. | 2002 Jan 11 |
|
Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. | 2002 Nov |
|
Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells. | 2003 Jun |
|
Lysine beta311 of protein geranylgeranyltransferase type I partially replaces magnesium. | 2004 Jul 16 |
|
Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells. | 2006 Mar 15 |
|
Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. | 2006 Sep 5 |
|
Screening of terpenes and derivatives for antimycobacterial activity; identification of geranylgeraniol and geranylgeranyl acetate as potent inhibitors of Mycobacterium tuberculosis in vitro. | 2007 Oct |
|
Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells. | 2009 Nov 1 |
|
Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol. | 2011 May 30 |
|
Dysfunction of vascular smooth muscle and vascular remodeling by simvastatin. | 2014 Apr |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:54:14 GMT 2023
by
admin
on
Fri Dec 15 17:54:14 GMT 2023
|
Record UNII |
AIA02AJA3A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7614-21-3
Created by
admin on Fri Dec 15 17:54:14 GMT 2023 , Edited by admin on Fri Dec 15 17:54:14 GMT 2023
|
PRIMARY | |||
|
GERANYLGERANIOL
Created by
admin on Fri Dec 15 17:54:14 GMT 2023 , Edited by admin on Fri Dec 15 17:54:14 GMT 2023
|
PRIMARY | |||
|
5281365
Created by
admin on Fri Dec 15 17:54:14 GMT 2023 , Edited by admin on Fri Dec 15 17:54:14 GMT 2023
|
PRIMARY | |||
|
AIA02AJA3A
Created by
admin on Fri Dec 15 17:54:14 GMT 2023 , Edited by admin on Fri Dec 15 17:54:14 GMT 2023
|
PRIMARY | |||
|
DTXSID301029793
Created by
admin on Fri Dec 15 17:54:14 GMT 2023 , Edited by admin on Fri Dec 15 17:54:14 GMT 2023
|
PRIMARY | |||
|
46762
Created by
admin on Fri Dec 15 17:54:14 GMT 2023 , Edited by admin on Fri Dec 15 17:54:14 GMT 2023
|
PRIMARY |